Lv1
58 积分 2023-10-27 加入
Discovery and Evaluation of DA-302168S as an Efficacious Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist
29天前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
1个月前
已完结
Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment
1个月前
已完结
Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss
1个月前
已完结
Amycretin in obesity: Mechanisms, clinical efficacy, and future perspectives
1个月前
已完结
Engineering of an Ultralong-Acting and Nonaggregating Dual Amylin and Calcitonin Receptor Agonist with Durable Efficacy in Obesity and Diabetes
1个月前
已完结
A Review of Amylin Peptide Receptor Activators for Obesity Pharmacotherapy
1个月前
已完结
The enduring metabolic improvement of combining dual amylin and calcitonin receptor agonist and semaglutide treatments in a rat model of obesity and diabetes
1个月前
已完结
Role of CRF 1 and CRF 2 receptors in fear and anxiety
2个月前
已完结
Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression
2个月前
已完结
皖公网安备34019202002308
